Effect of Amino Acids and Sugar Alcohols on Gastric Emptying and Release of Satiation Peptides in Humans

September 28, 2015 updated by: University Hospital, Basel, Switzerland

Effect of Amino Acids and Sugar Alcohols on Gastric Emptying and Release of Satiation Peptides in Normal Weight and Obese Subjects

With this study the investigators investigate the effects of amino acids (tryptophan in two different concentrations, leucin) and sugar alcohols (xylitol, erythritol) on satiety mechanisms.

Study Overview

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Basel, Switzerland
        • University Hospital Basel, Phase 1 Research Unit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy normal weight subjects with a body-mass index of 19.0-24.9
  • Healthy obese subjects with a body-mass index of > 30
  • Normal eating habits (no diets; no dietary changes; no special dietary habits, such as vegetarian/vegan)
  • Age 18-40 years
  • Stable body weight for at least three months

Exclusion Criteria:

  • Smoking
  • Substance abuse
  • Regular intake of medications (except for oral contraceptives)
  • Medical or psychiatric illness
  • History of gastrointestinal disorders
  • Food allergies
  • Pregnancy, breast feeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 0.52 g L-Tryptophan
0.52 g L-Tryptophan in 300 mL tap water (plus 50 mg 13C-sodium acetate) given via nasogastric tube
Active Comparator: 1.56 g L-Tryptophan
1.56 g L-Tryptophan in 300 mL tap water (plus 50 mg 13C-sodium acetate) given via nasogastric tube
Active Comparator: 1.56 g L-Leucine
1.56 g L-Leucine in 300 mL tap water (plus 50 mg 13C-sodium acetate) given via nasogastric tube
Active Comparator: 50 g Xylitol
50 g Xylitol in 300 mL tap water (plus 50 mg 13C-sodium acetate) given via nasogastric tube
Active Comparator: 75 g Erythritol
75 g Erythritol in 300 mL tap water (plus 50 mg 13C-sodium acetate) given via nasogastric tube
Placebo Comparator: 75 g Glucose
75 g Glucose in 300 mL tap water (plus 50 mg 13C-sodium acetate) given via nasogastric tube
Placebo Comparator: Tap water
300 mL tap water (plus 50 mg 13C-sodium acetate) given via nasogastric tube

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of different aminoacids and sugar alcohols on secretion of satiation hormones
Time Frame: changes from baseline to three hours after treatment
Plasma concentrations of glucose
changes from baseline to three hours after treatment
Effect of different aminoacids and sugar alcohols on secretion of satiation hormones
Time Frame: changes from baseline to three hours after treatment
Plasma concentrations of insulin are measured
changes from baseline to three hours after treatment
Effect of different aminoacids and sugar alcohols on secretion of satiation hormones
Time Frame: changes from baseline to three hours after treatment
Plasma concentrations of glucagon are measured
changes from baseline to three hours after treatment
Effect of different aminoacids and sugar alcohols on secretion of satiation hormones
Time Frame: changes from baseline to three hours after treatment
Plasma concentrations of glucagon-like Peptide (GLP-1) are measured
changes from baseline to three hours after treatment
Effect of different aminoacids and sugar alcohols on secretion of satiation hormones
Time Frame: changes from baseline to three hours after treatment
Plasma concentrations of PYY are measured
changes from baseline to three hours after treatment
Effect of different aminoacids and sugar alcohols on secretion of satiation hormones
Time Frame: changes from baseline to three hours after treatment
Plasma concentrations of cholecystokinin are measured
changes from baseline to three hours after treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of different aminoacids and sugar alcohols on gastric emptying
Time Frame: changes from baseline to four hours after treatment
measured by C13 breath test
changes from baseline to four hours after treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

March 1, 2015

Study Registration Dates

First Submitted

May 26, 2015

First Submitted That Met QC Criteria

September 28, 2015

First Posted (Estimate)

September 30, 2015

Study Record Updates

Last Update Posted (Estimate)

September 30, 2015

Last Update Submitted That Met QC Criteria

September 28, 2015

Last Verified

September 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endocrine System Diseases

Clinical Trials on 1.56 g L-Tryptophan

3
Subscribe